Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4787896
Max Phase: Preclinical
Molecular Formula: C30H25F5N4O5S
Molecular Weight: 648.61
Molecule Type: Unknown
Associated Items:
ID: ALA4787896
Max Phase: Preclinical
Molecular Formula: C30H25F5N4O5S
Molecular Weight: 648.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1NC(=O)c2cc(N(Cc3ccc(C4CCCCC4)cn3)C(=O)[C@H]3CCN3S(=O)(=O)c3c(F)c(F)c(F)c(F)c3F)ccc21
Standard InChI: InChI=1S/C30H25F5N4O5S/c31-22-23(32)25(34)27(26(35)24(22)33)45(43,44)39-11-10-21(39)30(42)38(18-8-9-19-20(12-18)29(41)37-28(19)40)14-17-7-6-16(13-36-17)15-4-2-1-3-5-15/h6-9,12-13,15,21H,1-5,10-11,14H2,(H,37,40,41)/t21-/m1/s1
Standard InChI Key: DFAZGBBGEGHQMP-OAQYLSRUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 648.61 | Molecular Weight (Monoisotopic): 648.1466 | AlogP: 4.70 | #Rotatable Bonds: 7 |
Polar Surface Area: 116.75 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.36 | CX Basic pKa: 4.50 | CX LogP: 4.04 | CX LogD: 4.00 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.17 | Np Likeness Score: -1.02 |
1. Brotherton-Pleiss C,Yue P,Zhu Y,Nakamura K,Chen W,Fu W,Kubota C,Chen J,Alonso-Valenteen F,Mikhael S,Medina-Kauwe L,Tius MA,Lopez-Tapia F,Turkson J. (2021) Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors., 64 (1.0): [PMID:33352047] [10.1021/acs.jmedchem.0c01705] |
Source(1):